 |
김효수 (서울대학교)
Education & Career
| 1978-1984 |
B. S., Seoul National University College of Medicine, |
| 1985-1987 |
M. S., Seoul National University College of Medicine, |
| 1987-1994 |
Ph. D., Seoul National University College of Medicine, |
| 1992-1994 |
Visiting Researcher, University of Tokyo, Japan, |
| 2000-2002, |
Visiting Scholar, St Elizabeth Medical Center, Boston, USA |
| 2009-Present |
Editorial board, Japanese Circulation Journal |
| 2005-Present |
Global or Asia-Pacific Advisory Board for companies as below (MSD, Astra-Zeneca, Beringer-Ingelheim, Sanofi-Aventis, Pfizer, Boston-Scientific, Medtronics, Abbott-Vascular) |
Representative papers
- PPAR-δActivates Endothelial Progenitor Cells to Induce Angio-myogenesis through MMP-9-mediated IGF-1 Paracrine Networks (2011). Eur. Heart J. 34(23):1755-65.
- Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation (2011). Arterioscler. Thromb. Vasc. Biol. 31(12):2798-805.
- Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardial integrin-beta1/ERK/caspase-9 phosphorylation cascade (2011). Mol. Med. 17(9-10):1095-106.
- N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells (2011). Mol Ther. 20(1):155-167.
- Human Peripheral blood-derived Sphere as a Niche for Hematopoietic Stem-Progenitor Cell Self-Renewal. (2011). Cell Research (in press). |
학회소개 